NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE151227 Query DataSets for GSE151227
Status Public on Nov 18, 2020
Title CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation(s) 32887696
Submission date May 26, 2020
Last update date Nov 18, 2020
Contact name Ryan D Chow
E-mail(s) ryan.chow@yale.edu
Organization name Yale University
Street address 850 West Campus Drive
City West Haven
State/province CT
ZIP/Postal code 06516
Country USA
 
Platforms (2)
GPL17021 Illumina HiSeq 2500 (Mus musculus)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
Samples (18)
GSM4568823 MA1L liver tumor cells transduced with sgKmt2d, replicate 1
GSM4568824 MA1L liver tumor cells transduced with sgKmt2d, replicate 2
GSM4568825 MA1L liver tumor cells transduced with sgKmt2d, replicate 3
This SuperSeries is composed of the following SubSeries:
GSE151225 CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade (RNA-Seq)
GSE151226 CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade (ATAC-Seq)
Relations
BioProject PRJNA635149

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE151227_RAW.tar 24.1 Mb (http)(custom) TAR (of NARROWPEAK, TSV)
SRA Run SelectorHelp

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap